Pre-administration of remifentanil in target-controlled propofol and remifentanil anesthesia prolongs anesthesia induction in neurosurgical patients A double-blind randomized controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Jin Hee | - |
dc.contributor.author | Kim, Doyeon | - |
dc.contributor.author | Chung, Ik Soo | - |
dc.contributor.author | Lee, Jeong Jin | - |
dc.contributor.author | Lee, Eun Kyung | - |
dc.contributor.author | Jeong, Ji Seon | - |
dc.date.accessioned | 2024-02-05T03:00:20Z | - |
dc.date.available | 2024-02-05T03:00:20Z | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.issn | 1536-5964 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71717 | - |
dc.description.abstract | Background: Pre- and co-administration of remifentanil in target-controlled propofol and remifentanil anesthesia are the most common methods in clinical practice. However, anesthesia induction time by timing remifentanil administration was not identified. Therefore, we investigated the induction time of anesthesia based on type of remifentanil administration in target-controlled anesthesia. Methods: A total of 60 patients were randomly assigned to 1 of 2 groups: Pre- administered with remifentanil before propofol infusion (Group R, n = 30) and co-administered with remifentanil with propofol (Group N, n = 30). The primary outcome was total induction time based on the order of remifentanil administration. Secondary outcomes were from start of the propofol infusion time to loss of consciousness (LOC), rocuronium onset time, time to Bispectral index (BIS) 60, and hemodynamic variables. Results: The mean +/- SD of total induction time was 180.5 +/- 49.0 s in Group N and 246.3 +/- 64.7 s in Group R (mean difference: 65.8 seconds; 95% CI: 35.0-96.5 s, P < .01). Time to BIS 60 and rocuronium onset time were longer in the Group R (P < .01 and P < .01, respectively). The Delta heart rate and Delta cardiac output values were lower in the Group R (P = .02 and P = .04, respectively). Injection pain was reported by 11 of 28 (39%) in the Group N and in 2 of 28 (7%) in the Group R (difference in proportion: 32%, 95% CI: 10-51%, P = .01). Conclusion: Pre- administration of remifentanil in target-controlled propofol and remifentanil anesthesia prolongs total induction time about 35% compared to co-administration of remifentanil and propofol by decreased CO. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.title | Pre-administration of remifentanil in target-controlled propofol and remifentanil anesthesia prolongs anesthesia induction in neurosurgical patients A double-blind randomized controlled trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1097/MD.0000000000014144 | - |
dc.identifier.bibliographicCitation | MEDICINE, v.98, no.3 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000462294100062 | - |
dc.identifier.scopusid | 2-s2.0-85060128549 | - |
dc.citation.number | 3 | - |
dc.citation.title | MEDICINE | - |
dc.citation.volume | 98 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | induction time | - |
dc.subject.keywordAuthor | neurosurgery | - |
dc.subject.keywordAuthor | propofol | - |
dc.subject.keywordAuthor | remifentanil | - |
dc.subject.keywordAuthor | target-controlled anesthesia | - |
dc.subject.keywordPlus | CARDIAC-OUTPUT | - |
dc.subject.keywordPlus | BISPECTRAL INDEX | - |
dc.subject.keywordPlus | INTRACRANIAL-PRESSURE | - |
dc.subject.keywordPlus | ACETYLCHOLINE-RELEASE | - |
dc.subject.keywordPlus | CEREBRAL-ISCHEMIA | - |
dc.subject.keywordPlus | ROCURONIUM | - |
dc.subject.keywordPlus | REDUCTION | - |
dc.subject.keywordPlus | FENTANYL | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | PHARMACODYNAMICS | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.